Skip to main content
OpenTrials
Completed

NCT Number: NCT05044585

Evaluation of RDS MultiSense® in Desaturation Analysis in Healthy Volunteers

In this clinical study, the investigators will compare vital parameters measurements obtained using continuous data from reference monitors and continuous wireless MultiSense® monitoring patch in 30 healthy volunteers under induced and controlled hypoxia.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hypoxia Pathological Conditions, Signs and Symptoms Signs and Symptoms Signs and Symptoms, Respiratory

Age range

18 year–50 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Clinical Investigation Center & Physiology and Functional Explorations unit at NHC

Strasbourg, 67000, France

About this study

The MultiSense® strip is a unique, band aid-sized, clinical signal quality, connected strip for real-time monitoring of cardio-respiratory parameters. The MultiSense® strip measures in real-time, remotely and continuously 11 clinical key-indicators by being attached to the patient thorax: ECG trace, heart rate, oxygen saturation, respiratory rate and relative respiration depth, pulse transit time, plethysmographic trace, perfusion index, skin temperature, physical activity and body position. Designed to be worn continuously for at least seven days, the patient can keep the patch during his sleep or in the shower.

The aim of this study is to determine the quality of measurements of arterial blood saturation (SpO2) provided by the MultiSense® system in comparison to measurements made with a reference Pulse Oximetry System under induced hypoxia, in terms of accuracy.

The study population includes 30 healthy volunteers.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Men or women between 18 to 50 years of age.
  • Subject able to receive and understand information related to the study and give written informed consent.
  • Subject is a non-smoker or an ex-smoker (stopped smoking for at least 6 months).
  • Subject demographics include a range of dark skin pigmentations, including at least 30% of the total pool, assessed by phototypes V and VI according to the Fitzpatrick scale (Questionnaire score between 28 and 40).
  • Subject is healthy (assessed by a physical examination AND normal ECG AND absence of medical treatment except for the birth control pill).
  • Subject authorizing the treatment of their personal data collected during the study (box checked in the consent form).
  • Subject affiliated to the French social security system.

Exclusion criteria

  • Subject with antecedent of allergies to adhesives or silicone or a skin disease that would preclude the use of an adhesive.
  • Subject with an implantable device such as a pacemaker.
  • Pregnant or lactating women (assessed by a negative ß-HCG test).
  • Subject with a high-altitude stay during the previous 4 weeks (more than 1 week spent over 3,500 meters).
  • Subject with Raynaud's syndrome.
  • Subject in exclusion period (determined by a previous or a current study).
  • Subject under guardianship or trusteeship.
  • Subject under the protection of justice.

Treatment and study plan

Remote Automated Monitoring System

Other

The subject will be monitored with conventional monitoring devices as well as the MultiSense patch.

Primary outcomes

  1. Determination of the quality of measurements of arterial blood saturation (SpO2) provided by the MultiSense® system in comparison to measurements made with a reference Pulse Oximetry System, in terms of accuracy.

    Time frame: from patch placement to patch removal, assessed up to 3 hours

    Accuracy is defined as an average measurement variation less than 3.5% of the mean value to the reference standard. The data for analysis will be equally distributed across the SpO2 range of 70-100%.

Secondary outcomes

  1. Descriptive kinetic of circulating oxidative stress markers under hypoxia conditions

    Time frame: from patch placement to patch removal, assessed up to 3 hours

    comparison of circulating oxidative stress and plasma antioxidant activity markers in blood between hypoxia and normal oxygenation conditions by dosage of anion superoxide (µmol/min)

  2. Descriptive kinetic of circulating oxidative stress markers under hypoxia conditions

    Time frame: from patch placement to patch removal, assessed up to 3 hours

    comparison of circulating oxidative stress and plasma antioxidant activity markers in blood between hypoxia and normal oxygenation conditions by dosage of lipids peroxidation (µg/mL)

  3. Descriptive kinetic of circulating oxidative stress markers under hypoxia conditions

    Time frame: from patch placement to patch removal, assessed up to 3 hours

    comparison of circulating oxidative stress and plasma antioxidant activity markers in blood between hypoxia and normal oxygenation conditions by dosage of protein carbonylation (ng/mL)

  4. Descriptive kinetic of circulating oxidative stress markers under hypoxia conditions

    Time frame: from patch placement to patch removal, assessed up to 3 hours

    comparison of circulating oxidative stress and plasma antioxidant activity markers in blood between hypoxia and normal oxygenation conditions by dosage of catalase (U/mg protein)

  5. Descriptive kinetic of circulating oxidative stress markers under hypoxia conditions

    Time frame: from patch placement to patch removal, assessed up to 3 hours

    comparison of circulating oxidative stress and plasma antioxidant activity markers in blood between hypoxia and normal oxygenation conditions by dosage of superoxide dismutase (U/mg protein)

  6. Descriptive kinetic of circulating oxidative stress markers under hypoxia conditions

    Time frame: from patch placement to patch removal, assessed up to 3 hours

    comparison of circulating oxidative stress and plasma antioxidant activity markers in blood between hypoxia and normal oxygenation conditions by dosage of glutathione (µmol/g protein)

  7. Comparison of Mitochondrial respiration from PBMCs between hypoxia and normal oxygenation conditions.

    Time frame: from patch placement to patch removal, assessed up to 3 hours

    Mitochondrial respiration from PBMCs is assessed by high-resolution respirometry by analysis of the kinetic of the respirometry results and comparison between each hypoxia /post-hypoxia data point with the baseline.

  8. To evaluate the impact of skin pigmentation on SpO2 determination by the MultiSense® solution.

    Time frame: from patch placement to patch removal, assessed up to 3 hours

    Comparison of the MultiSense® SpO2 performances with the reference between light and dark-pigmented subjects. Qualitative comparison of the raw PPG signal between light and dark-pigmented skin subjects.

  9. To evaluate pulse transit time (PTT) as an indicator of blood pressure (BP) variation.

    Time frame: from patch placement to patch removal, assessed up to 3 hours

    Comparison of blood pressure variation measured by a standard cuff device with PTT variation measured by the MultiSense® acquisition system.

  10. To evaluate the reliability of the respiration rate determined by the MultiSense® solution

    Time frame: from patch placement to patch removal, assessed up to 3 hours

    Determination of the quality of respiration rate provided by the MultiSense® patch in comparison to measurements made with reference medical devices in the hospital setting, in terms of accuracy. Accuracy is defined as an average measurement variation less than 5% of the respiration rate mean value to the reference standard.

  11. To compare the quality of MultiSense® data from a patch worn on the chest and from a patch worn on the upper back in different body posture and to evaluate the impact of strip exact localization on the chest.

    Time frame: from patch placement to patch removal, assessed up to 3 hours

    Qualitative comparison of the raw PPG signal between the two patches location for each subject (chest and back). Comparison of the SpO2 derived by each MultiSense® patch to the reference during the resting period in different lying positions (supine, prone, left and right side).

Sponsors and collaborators

Lead sponsor

IHU Strasbourg

Other

Collaborators

  • Rhythm Diagnostic Systems

Registry information

Official study title

Evaluation of RDS MultiSense® in Desaturation Analysis and Effects of Hypoxia on Circulating Oxidative Stress and Mitochondrial Respiration in Healthy Volunteers

Acronym: HYPO

Important dates

Study start
2021
Primary completion
2022
Study completion
2022
First posted
Sep 16, 2021
Registry last updated
Feb 28, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.